3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: July 31, 2023
Period of Report: July 27, 2023
Accession Number: 0001127602-23-021545

View Document ↗ View on SEC.gov ↗